Arkolith/Insider Trading/NEXI/Form 4

Verstandig Grant

DirectorNexImmune, Inc. (NEXI) · full profile →Form 4 · filed Apr 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 4, 2023Disposed to issuer(D)39K——0
Apr 4, 2023Disposed to issuer(D)62K——0
Apr 4, 2023Grant(A)5K——5K
Apr 4, 2023Grant(A)34K——34K
Apr 4, 2023Grant(A)62K——62K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-023688) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML